Showing results (1461-1470 of 1,597) with videos related to

Sort By:
Pageof 160
Medicine|January 9, 2020
Serial anti-tuberculous immune responses during the follow-up of patients with tuberculous pleurisyBing-Yan Zhang, Zhi-Min Yu, Qing-Luan Yang, et al.
International Immunopharmacology|February 19, 2025
Perillaldehyde targeting PARP1 to inhibit TRPM2-CaMKII/CaN signal transduction in diabetic cardiomyopathyQian-Qian Niu, Zhan-Zhou Fu, Bing-Yan Mao, et al.
World Journal of Gastroenterology|November 24, 2025
Clinical predictors of multidrug-resistant Gram-negative pyogenic liver abscess and nomogram construction: A retrospective analysisKe Xu, Dong-Hui Wu, Chu-Jia Zeng, et al.
Oncotarget|January 2, 2018
Oridonin synergistically enhances JQ1-triggered apoptosis in hepatocellular cancer cells through mitochondrial pathwayHua-Peng Zhang, Gong-Quan Li, Wen-Zhi Guo, et al.
Bioorganic & Medicinal Chemistry Letters|February 26, 2004
1-(2-Naphthyl)-1H-pyrazole-5-carboxylamides as potent factor Xa inhibitors. Part 3: Design, synthesis and SAR of orally bioavailable benzamidine-P4 inhibitorsZhaozhong J Jia, Yanhong Wu, Wenrong Huang, et al.
Chinese Medical Journal|January 11, 2020
Assessing the association of appropriateness of coronary revascularization and 1-year clinical outcomes for patients with stable coronary artery disease in ChinaShen Lin, Heng Zhang, Chen-Fei Rao, et al.
Bioorganic & Medicinal Chemistry Letters|March 12, 2004
Design, synthesis, and SAR of anthranilamide-based factor Xa inhibitors incorporating substituted biphenyl P4 motifsPenglie Zhang, Liang Bao, Jingmei F Zuckett, et al.
Oncotarget|November 18, 2015
Suppression of BRD4 inhibits human hepatocellular carcinoma by repressing MYC and enhancing BIM expressionGong-Quan Li, Wen-Zhi Guo, Yi Zhang, et al.
Experimental and Therapeutic Medicine|February 28, 2020
Extracellular production of recombinant <i>sus scrofa</i> trefoil factor 3 by <i>Brevibacillus choshinensis</i>He-Ping Li, Chun-Mei Xu, Bing-Yan Wen, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|July 18, 2014
Optical coherence tomography assessment of a PLGA-polymer with electro-grafting base layer versus a PLA-polymer sirolimus-eluting stent at three-month follow-up: the BuMA-OCT randomised trialJie Qian, Yao-Jun Zhang, Bo Xu, et al.
Pageof 160